🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Very few patients with endocrine-resistant, hormone-receptor positive metas...
Status
Recruiting
Location
Shaare Zedek Medical Center
Start Date
2019-04-18
Trial ID
NCT03591276
Treatments Being Tested
This research study is testing the combination of two drugs, sargramostim a...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-04-16
Trial ID
NCT04703426
Treatments Being Tested
In this study we are evaluating the safety and feasibility of the triple co...
Status
Recruiting
Location
UF Health Shands Hospital
Start Date
2024-12-10
Trial ID
NCT06558214
Treatments Being Tested
To evaluate the safety, tolerability, and anti-tumor activity of galinpepim...
Status
Completed
Location
St. Joseph Heritage Healthcare
Start Date
2019-09-30
Trial ID
NCT03761914
Treatments Being Tested
This pilot study is evaluating how well pembrolizumab and combination chemo...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2020-11-24
Trial ID
NCT04383743
The purpose of this study is to assess the safety and tolerability and to e...
Status
Active Not Recruiting
Location
Sanford Cancer Center ( Site 0005)
Start Date
2022-06-16
Trial ID
NCT05382325
Treatments Being Tested
The purpose of this study is to compare the efficacy of pembrolizumab + len...
Status
Completed
Location
Anhui Cancer Hospital-Gynecological Oncology ( Site 2509)
Start Date
2019-10-22
Trial ID
NCT04865289
Treatments Being Tested
This study is to assess the safety and antitumor activity of ABL103 plus pe...
Status
Recruiting
Location
UH Cleveland Medical Center
Start Date
2025-08-06
Trial ID
NCT07158918
Treatments Being Tested
This is a Phase 2b, randomized, open label study to assess the safety and e...
Status
Recruiting
Location
Compassionate Cancer Care Medical Group
Start Date
2021-06-18
Trial ID
NCT04920617
Treatments Being Tested
This is an open label Pilot study to evaluate the combination of Vigil™ and...
Status
Completed
Location
Texas Oncology P.A., Texas Cancer Center
Start Date
2015-10
Trial ID
NCT02574533
Treatments Being Tested